<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03725839</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-249</org_study_id>
    <nct_id>NCT03725839</nct_id>
  </id_info>
  <brief_title>The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
  <official_title>The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed to evaluate the performance as well as the patients overall
      acceptance of the interface.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A minimum of 40 OSA participants who currently use CPAP will be recruited for the trial.
      Participant will be in the trial for three weeks- first week will be a collection of Positive
      Airway Pressure baseline data on participant's usual interface. The participant will then use
      the trial interface in-home for 2 weeks. There is also an option of a six month extension if
      the participant wish to continue on the trial interface.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 5, 2018</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trial Mask usability</measure>
    <time_frame>14 ± 4 days in home</time_frame>
    <description>Questionnaire on ease-of-use (very easy to very difficult) Subjective</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trial mask Performance</measure>
    <time_frame>14 ± 4 days in home</time_frame>
    <description>Questionnaire on performance (very good to very poor)- Subjective</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trial mask Reliability</measure>
    <time_frame>5 months and 2 weeks in home</time_frame>
    <description>Questionnaire on reliability - Subjective</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trial mask performance measured in L/min</measure>
    <time_frame>14 ± 4 days in home</time_frame>
    <description>Objective leak data from PAP device</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>F&amp;P Interface will be used by OSA participants in-home for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>F&amp;P Interface</intervention_name>
    <description>F&amp;P Interface to be used for OSA therapy</description>
    <arm_group_label>Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (18+ years of age)

          -  Able to give written consent

          -  AHI ≥ 5 on diagnostic night

          -  Either prescribed APAP, CPAP or Bi-level PAP for OSA

        Exclusion Criteria:

          -  Inability to give written consent

          -  Anatomical or physiological conditions making PAP therapy inappropriate

          -  Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)

          -  Current diagnosis of respiratory disease or CO2 retention

          -  Pregnant or may think they are pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bhavi Ogra</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Manager</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hawkes Bay Fallen Soldiers' Memorial Hospital</name>
      <address>
        <city>Hastings</city>
        <state>Hawkes Bay</state>
        <zip>4120</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fisher &amp; Paykel Healthcare</name>
      <address>
        <city>Auckland</city>
        <zip>2013</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Well Sleep</name>
      <address>
        <city>Wellington</city>
        <zip>6035</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

